Mark Lappe, Director, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), bought 30,300 shares at $6.23 ($198K) on 2008-10-10, disclosed to the SEC on 2008-10-14.
Open-market purchase of $198k RPRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.23 | 15,300 | $95K | 48.2% |
| 2 | $6.82 | 15,000 | $102K | 51.8% |
| Total | $6.52 avg | 30,300 | $198K | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |